All Posts

Build confident GMP audits with five essential auditor skills, practical risk-based techniques, and ready-to-use checklists. Learn how to assess regulatory expectations, uncover compliance gaps, and follow through on CAPAs to support stronger, more effective quality systems.
CTD Module 3 contains the quality and CMC evidence regulators use to assess drug substance and drug product quality. This technical guide explains the section map, content expectations, and critical cross-checks.
Revalidation in pharma helps confirm that processes, equipment, and systems remain fit for intended use. Learn key GMP triggers, risk-based decisions, and records needed to maintain a validated state.
Learn how pharma management reviews turn quality data into critical decisions on deviations, complaints, CAPA effectiveness, resources, and continual improvement.
Learn how to plan risk-based GMP self-inspections, collect reliable audit evidence, write clear findings, and verify CAPA effectiveness. This practical guide includes pharma audit examples, useful metrics, and eight technical visuals.
Build 6M Ishikawa diagrams to explore potential causes across Man, Machine, Method, Material, Measurement, and Mother Nature (Environment). Test each cause against documented GMP evidence, investigate deviations systematically, and distinguish confirmed root causes from assumptions. Then define CAPA that addresses the cause and verify its effectiveness to help prevent recurrence.
Medical device regulation is evolving in 2026. Discover how FDA QMSR, EU MDR requirements, and UK rules shape device classification, market access, inspections, and post-market surveillance, with practical guidance for manufacturers seeking stronger quality systems and compliance.
How does FDA accelerated approval affect drug development and GMP compliance? Explore clinical evidence requirements, confirmatory trials, postmarketing obligations, and inspection readiness. Learn how pharmaceutical manufacturers can reduce regulatory risks and prepare for FDA approval decisions in 2026.
Explore 5 critical differences between deviation and nonconformance in pharma, including GMP investigations, OOS, risk assessment, and CAPA.
Explore 6 powerful root cause analysis methods in pharma to investigate deviations, strengthen CAPA, ensure GMP compliance, and protect patient safety.